BioSyent Inc. (OTCMKTS:BIOYF – Get Free Report) shot up 0.9% during mid-day trading on Thursday. The stock traded as high as $12.42 and last traded at $12.42. 1,639 shares traded hands during trading, a decline of 32% from the average daily volume of 2,396 shares. The stock had previously closed at $12.31.
BioSyent Stock Performance
The firm’s 50 day moving average price is $11.70 and its two-hundred day moving average price is $10.82.
About BioSyent
BioSyent Inc is a Canadian specialty pharmaceutical company focused on acquiring, licensing, developing and commercializing products for the Canadian healthcare market. Through its BioSyent Pharma subsidiary, the company concentrates on prescription and non-prescription therapies that address specific medical needs and can be supported through focused sales and marketing activities.
BioSyent’s product portfolio has included FeraMAX, an oral iron supplement designed to help treat or prevent iron deficiency and iron-deficiency anemia.
See Also
- Five stocks we like better than BioSyent
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.
